Institute for Cancer Research
Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.
The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.
Scientific director
Scientific production - Institute for Cancer Research
| Publications | |
| 2012 | so far |
| 2011 | 184 |
| 2010 | 199 |
| 2009 | 167 |
| 2008 | 143 |
Print this page [86663 visits]Latest news
Presentation of prestigious research project
Actionable Targets in Cancer Metastasis (MetAction) – from Bed to Bench to Byte to Bedside
This research project - entitled "Actionable Targets in Cancer Metastasis - from Bed to Bench to Byte to Bedside" - and focusing on intratumoral heterogeneity and personal-adapted treatment of metastatic melanoma, breast-and colorectal carcinoma - has recently been granted with 22.8 mill NOK from the Norwegian Research Council.
The granted project is based in an integrated collaboration between basic research- and clinical departments located either at Oslo University Hospital (OUS) or Akershus University Hospital (Ahus) and is funded for four years. Principle Investigators are Gunhild M. Mælandsmo from Department of Tumor Biology and Anne-Lise Børresen-Dale from the Department of Genetics, both at Institute for Cancer Research, OUS.
GAP cancer conference in Oslo May 14-16
Global Academic Programs 2012
The 2012 Global Academic Programs conference is held at Holmenkollen Park Hotel in Oslo from May 14-16. The GAP Annual Conference provides a forum for faculty from MD Anderson and their sister institutions to develop collaborations and exchange research results and ideas. The event is held at MD Anderson in odd years and is hosted by a Sister Institution in even years.
Starting in 2012, the GAP Annual Conference will travel every other year to a Sister Institution, rotating around different regions of the globe. The first external conference is hosted by the Norwegian Cancer Consortium (NCC), which includes Stavanger University Hospital, The Norwegian Radium Hospital at OUS, and the National Cancer Registry of Norway.
All plenary lectures and workshops will be filmed and made available on http://webtv.oncolex.no/ after the conference.
Study by Ane Hansen Kjenseth et al. featured on the cover of Journal of Biological Chemistry
A study by PhD student Ane Hansen Kjenseth (photo) and colleagues at Department of Cancer Prevention, Institute for Cancer Research and Centre for Cancer Biomedicine, has identified a novel mechanism for regulation of intercellular communication. The article was published in the May 4 issue of Journal of Biological Chemistry, and was featured on the cover of the journal.
Kirsten Sandvig appointed "Scientist of the Month" by "Helse Sør-Øst" for April 2012
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by by calling special attention to a "Scientist of the month".
For the month of March 2012, this honor goes to Kirsten Sandvig from the Department of Biochemstry at the Institute for Cancer Research, Oslo University Hospital.
Nature article describing 2000 breast tumors reveals new subgroups
Department of Genetics has been involved in an article presented in Nature (journal impact factor 36.10). By integrating the copy number and gene expression of 2000 breast tumors, novel subgroups of breast cancer with distinct clinical outcome were revealed. Copy number was associated with expression in ~40% of genes. Co-authors from the Department of Genetics are Anita Langerød and Anne-Lise Børresen-Dale.
May 7, 2012
Latest publications
Inst. for Cancer Research
Synthesis of Highly Efficient, Ca-Based, Al(2) O(3) -Stabilized, Carbon Gel-Templated CO(2) Sorbents
Adv Mater (in press)
PubMed 22570251
Selective autophagy in Drosophila
Int J Cell Biol, 2012, 146767
PubMed 22567011
Doping analyses are not on safe ground
Tidsskr Nor Laegeforen, 132 (8), 929-930
PubMed 22562317
Selected publications
Journal Impact Factor > 5, first or last author from the Institute for Cancer Research
Synthesis of Highly Efficient, Ca-Based, Al(2) O(3) -Stabilized, Carbon Gel-Templated CO(2) Sorbents
Adv Mater (in press)
PubMed 22570251
Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3
Mol Cell Proteomics (in press)
PubMed 22457534
Efficient siRNA Targeted Delivery into Cancer Cells by Gastrin-Releasing Peptides
Bioconjug Chem (in press)
PubMed 22443209
